These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16207728)

  • 1. Understanding variation in measles-mumps-rubella immunization coverage--a population-based study.
    Wright JA; Polack C
    Eur J Public Health; 2006 Apr; 16(2):137-42. PubMed ID: 16207728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMR vaccine uptake rates: a data validation study.
    Ghebrehewet S; Falconer M; McDonald P; Schlecht B
    Commun Dis Public Health; 2003 Jun; 6(2):144-6. PubMed ID: 12889295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of socioeconomic deprivation on uptake of measles, mumps and rubella vaccination in Liverpool, UK over 16 years: a longitudinal ecological study.
    Hungerford D; Macpherson P; Farmer S; Ghebrehewet S; Seddon D; Vivancos R; Keenan A
    Epidemiol Infect; 2016 Apr; 144(6):1201-11. PubMed ID: 26542197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of geographical variation in income measures on measles-mumps-rubella uptake and coverage in England; a protocol for an ecological study.
    Ghazal S; Soyiri IN
    PLoS One; 2023; 18(6):e0280008. PubMed ID: 37379282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an association between the coverage of immunisation boosters by the age of 5 and deprivation? An ecological study.
    Sandford H; Tata LJ; Browne I; Pritchard C
    Vaccine; 2015 Feb; 33(9):1218-22. PubMed ID: 25527213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys.
    Ramsay ME; Yarwood J; Lewis D; Campbell H; White JM
    Br J Gen Pract; 2002 Nov; 52(484):912-6. PubMed ID: 12434960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving MMR vaccination rates: herd immunity is a realistic goal.
    Cockman P; Dawson L; Mathur R; Hull S
    BMJ; 2011 Oct; 343():d5703. PubMed ID: 21971162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
    Simone B; Balasegaram S; Gobin M; Anderson C; Charlett A; Coole L; Maguire H; Nichols T; Rawlings C; Ramsay M; Oliver I
    Vaccine; 2014 Aug; 32(36):4681-8. PubMed ID: 24996125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles immunization of 2-year-olds in a rural southern state.
    Feldman S; Andrew M; Gilbert J; Bracken B; Thompson FE
    JAMA; 1994 May; 271(18):1417-20. PubMed ID: 8176803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles, mumps, and rubella vaccine coverage in 2 year old children in East Lancashire--better than it looks.
    Clark A; Marshall R
    Commun Dis Public Health; 1999 Jan; 2(1):50-3. PubMed ID: 10462897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
    Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
    Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could it happen here? Vaccine risk controversies and the specter of derailment.
    Colgrove J; Bayer R
    Health Aff (Millwood); 2005; 24(3):729-39. PubMed ID: 15886167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the safety and immunogenicity of lyophilized live attenuated measles-mumps-rubella combined vaccine].
    Liu G; Fang H; Feng Z; Guo W; Dong C; Zhang W; Ze W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Dec; 23(6):435-7. PubMed ID: 12667354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.